Drug interactions Side effects Safety Contacting a doctor Summary Salmeterol belongs to a class of drugs called bronchodilators
Salmeterol is used to control wheezing, shortness of breath, coughing, and chest tightness in people with chronic obstructive pulmonary disease (COPD; a group of lung diseases
Introduction Salmeterol xinafoate is a racemic form of the 1-hydroxy-2-naphthoic acid salt of salmeterol
Salmeterol inhalation is a bronchodilator that is used to prevent asthma attacks or exercise-induced bronchospasm
Fluticasone and salmeterol inhalation is a steroid and bronchodilator combination medicine that is used to prevent asthma attacks
, 1992 , Bergendal et al A precipitation process is used to produce combined particles consisting of two antiasthmatic drugs: salmeterol xinafoate and fluticasone propionate
The hydrophilic tail of salmeterol binds to leucine residues in the exo-site of the beta-2 adrenoceptor almost irreversibly Salmeterol is hypothesized to bind to 2 sites on the beta-2 adrenoceptor
Patients should be advised to report any deterioration in symptoms
The hydrophilic tail of salmeterol binds to leucine residues in the exo-site of the beta-2 adrenoceptor almost irreversibly Salmeterol is a selective, long acting ß2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction
Symptoms of bronchospasm include shortness of breath, wheezing, coughing and chest tightness
Formoterol and salmeterol are both long-acting bronchodilators that are effective in the treatment of asthma (Lötvall 2001)
Fluticasone Propionate is corticosteroid with potent anti-inflammatory activity
Salmeterol is a selective, long acting ß2 agonist used in the treatment of asthma and other forms of diffuse airways obstruction
Example; Exercise 2
The key behavior of salmeterol, and other long-acting β 2-agonists, is that of reassertion
Protection may last up to 9 hours in adolescents and up to 12 hours in pediatrics aged 4 to 11 years, when used intermittently as needed for prevention